Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial. - Gunst JD; Staerke NB; Pahus MH; Kristensen LH; Bodilsen J; Lohse N; Dalgaard LS; Brønnum D; Fröbert O; Hønge B; Johansen IS; Monrad I; et al. (EClinicalMedicine, 2021)